IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Commodore Capital LP

Q3 2021 Holdings

Filed 2021-11-15 | 29 holdings | $135.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics Inc(ACRS)COM00461U105$39.4M2,190,29129.1%
Cytokinetics Inc(CYTK)COM NEW23282W605$28.5M796,57821.0%
C4 Therapeutics Inc(CCCC)COM STK12529R107$21.5M481,09415.8%
Celcuity Inc(CELC)COM15102K100$16.6M920,46412.2%
Cogent Biosciences Inc(COGT)COM19240Q201$16.1M1,912,51111.9%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$13.4M248,2079.9%
Iveric BIO Inc(OPHTEUR)COM46583P102$44.7K2,750,1370.0%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$26.1K1,292,2510.0%
Kura Oncology Inc(KURA)COM50127T109$18.7K999,4330.0%
Merus N VCOMN5749R100$15.8K718,1360.0%
Cymabay Therapeutics Inc(CBAYUSD)COM23257D103$15.2K4,169,8960.0%
Satsuma Pharmaceuticals IncCOM80405P107$14.5K3,118,7610.0%
Vistagen Therapeutics Inc(VTGNUSD)COM NEW92840H202$14.0K5,123,5090.0%
Viridian Therapeutics Inc(VRDN)COM92790C104$11.0K667,6740.0%
Tenaya Therapeutics Inc(TNYA)COM87990A106$10.6K513,9300.0%
Iovance Biotherapeutics Inc(IOVA)COM462260100$8.9K362,8690.0%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$8.9K579,4320.0%
Protagonist Therapeutics Inc(PTGX)COM74366E102$8.8K498,0790.0%
Kronos BIO Inc(KRON1USD)COM50107A104$6.3K298,8390.0%
Revolution Medicines Inc(RVMD)COM76155X100$6.2K226,2280.0%
Genocea Biosciences Inc(GNCAQ)COM NEW372427401$5.9K3,079,7560.0%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$5.5K312,5530.0%
Dyne Therapeutics Inc(DYN)COM26818M108$5.0K305,1250.0%
Mereo Biopharma Group PLC(MREO)ADS589492107$4.8K1,972,9580.0%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$3.7K125,0000.0%
Inventiva SA(IVA)ADS46124U107$3.7K262,6580.0%
Bcls Acquisition CorpCOM CL AG0904B105$2.5K250,0000.0%
Astria Therapeutics Inc(CATBUSD)COM04635X102$2.1K239,2700.0%
Silverback Therapeutics Inc(SPRY)COM82835W108$96997,1430.0%